# EDGAR Filing Document

**Accession Number:** 0001766140
**File Stem:** 9999999995-26-001996
**Filing Date:** 2026-6
**Character Count:** 1314
**Document Hash:** 657e3875c299864b295ee5691bd6cd58
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-001996.hdr.sgml**: 20260616

**ACCESSION NUMBER**: 9999999995-26-001996

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260615

**DATE AS OF CHANGE**: 20260616

**EFFECTIVENESS DATE**: 20260615

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Unicycive Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001766140
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 813638692
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296545
- **FILM NUMBER:** 261092790

**BUSINESS ADDRESS:**
- **STREET 1:** 1975 W. EL CAMINO REAL, SUITE 204
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94040
- **BUSINESS PHONE:** 650-384-0642

**MAIL ADDRESS:**
- **STREET 1:** 1975 W. EL CAMINO REAL, SUITE 204
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94040

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** June 15, 2026

**Time:** 17:00:00

**Form Type:** S-3

---

**CIK:** 0001766140

**Company Name:** Unicycive Therapeutics, Inc.

**File Number:** 333-296545